Literature DB >> 3494743

Factors affecting antimicrobial susceptibility of Fusobacterium species.

M D Rowland, V E Del Bene, J W Lewis.   

Abstract

Fifteen clinical isolates of Fusobacterium species were studied to determine their quality of growth on five agar media, their susceptibility to penicillin, cephalothin, cefoxitin, and cefotaxime, the inoculum effect, and the presence of L forms and beta-lactamase. Wilkins-Chalgren agar supported confluent growth best, but Fusobacterium nucleatum exhibited poor growth on all agar media. Most isolates exhibited poor reproducibility of MIC results with repeated agar dilution testing. However, most isolates were susceptible to all antibiotics at the breakpoint concentrations. No inoculum effect was observed, but preparation of an inoculum at a 0.5 McFarland nephelometric standard produced a lower than expected number of CFU (10(6) CFU) in some isolates. L forms were frequently seen. No beta-lactamase was found. The variability in MICs seen with beta-lactam antibiotics was not found when clindamycin was tested. MIC studies with Fusobacterium spp. may be complicated by poor growth on agar media, poor reproducibility, and small inoculum size.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494743      PMCID: PMC265956          DOI: 10.1128/jcm.25.3.476-479.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Medium for use in antibiotic susceptibility testing of anaerobic bacteria.

Authors:  T D Wilkins; S Chalgren
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

2.  Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria.

Authors:  V L Sutter; A L Barry; T D Wilkins; R J Zabransky
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

3.  Antibiotic sensitivity testing of anaerobic bacteria by the breakpoint method.

Authors:  U Höffler; G Pulverer
Journal:  Chemotherapy       Date:  1984       Impact factor: 2.544

4.  In-vitro activity of ceftizoxime against anaerobic bacteria and comparison with other cephalosporins.

Authors:  A W Chow; S M Finegold
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

5.  Susceptibility testing of anaerobic bacteria.

Authors:  S M Finegold; R D Rolfe
Journal:  Diagn Microbiol Infect Dis       Date:  1983-03       Impact factor: 2.803

6.  Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.

Authors:  W E Owens; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

7.  Rapid beta-lactamase testing in bacteroides.

Authors:  E L Gabay; V L Sutter; S M Finegold
Journal:  J Antimicrob Chemother       Date:  1981-11       Impact factor: 5.790

8.  Susceptibility of anaerobic bacteria to 23 antimicrobial agents.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

9.  Susceptibility of intestinal anaerobes to new beta-lactam antibiotics.

Authors:  M B Bansal; S K Chuah; H Thadepalli
Journal:  Chemotherapy       Date:  1984       Impact factor: 2.544

Review 10.  Gram-negative anaerobic bacilli: Their role in infection and patterns of susceptibility to antimicrobial agents. II. Little-known Fusobacterium species and miscellaneous genera.

Authors:  W L George; B D Kirby; V L Sutter; D M Citron; S M Finegold
Journal:  Rev Infect Dis       Date:  1981 May-Jun
View more
  8 in total

1.  National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteria.

Authors:  W J Brown
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

2.  Fastidious anaerobe agar compared with Wilkins-Chalgren agar, brain heart infusion agar, and brucella agar for susceptibility testing of Fusobacterium species.

Authors:  J S Brazier; E J Goldstein; D M Citron; M I Ostovari
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Cell-wall-defective variants of Fusobacterium.

Authors:  C C Johnson; H M Wexler; S Becker; M Garcia; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

4.  Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 5.  Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum.

Authors:  A I Bolstad; H B Jensen; V Bakken
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

6.  Comparison of extracellular enzymes of Fusobacterium necrophorum subsp. necrophorum and Fusobacterium necrophorum subsp. funduliforme.

Authors:  K K Amoako; Y Goto; T Shinjo
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

7.  Antimicrobial susceptibility testing of Bilophila wadsworthia by using triphenyltetrazolium chloride to facilitate endpoint determination.

Authors:  P Summanen; H M Wexler; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

8.  Changes in the Microbiome Profile in Different Parts of the Intestine in Piglets with Diarrhea.

Authors:  Mariya V Gryaznova; Yuliya D Dvoretskaya; Mikhail Y Syromyatnikov; Sergey V Shabunin; Pavel A Parshin; Evgeniy V Mikhaylov; Nikolay A Strelnikov; Vasily N Popov
Journal:  Animals (Basel)       Date:  2022-01-28       Impact factor: 2.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.